Zee Laboratories Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 10.09 Cr
as on 05-07-2024
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.95 Cr
as on 05-07-2024
- Revenue 5.16%
(FY 2023)
- Profit -61.45%
(FY 2023)
- Ebitda -60.18%
(FY 2023)
- Net Worth 8.48%
(FY 2023)
- Total Assets 1.28%
(FY 2023)
About Zee Laboratories
The Corporate was formerly known as Zee Herbal Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 10.09 Cr.
The company has closed loans amounting to ₹8.95 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zee Laboratories Limited India are Sat Singh as Cfo, Puneet Khurana as Company Secretary, and Rohan Mukul as Ceo. Rajeev Mukul, Anil Mehta, Dhananjay Kumar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PLC061704
- Company No.
061704
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Sep 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zee Laboratories Limited offer?
Zee Laboratories Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Cosmetics, Hair & Beauty Products, Body Care Products, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Anti Inflammatory Drugs, Deflazacort Tablets.
Who are the key members and board of directors at Zee Laboratories?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Mukul  | Managing Director | 23-Sep-1994 | Current |
| Sat Singh | CFO | 21-Mar-2023 | Current |
| Puneet Khurana | Company Secretary | 01-May-2023 | Current |
| Rohan Mukul | CEO | 07-Aug-2018 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Mehta | Director | 29-Jul-2019 | Current |
| Dhananjay Kumar | Director | 30-Aug-2018 | Current |
| Deepak Bambha | Director | 29-Jul-2019 | Current |
| Aarzoo Sharma | Director | 29-Jul-2023 | Current |
| Harish Pathak | Additional Director | Current |
Financial Performance of Zee Laboratories.
Zee Laboratories Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.16% increase. The company also saw a substantial fall in profitability, with a 61.45% decrease in profit. The company's net worth moved up by a moderate rise of 8.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zee Laboratories?
In 2023, Zee Laboratories had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 29 Jan 2015 | ₹4.95 Cr | Satisfied |
State Bank Of India Creation Date: 25 Feb 2010 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Zee Laboratories?
Zee Laboratories has a workforce of 517 employees as of May 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zee Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zee Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
